Long-term protection of HPV test in women at risk of cervical cancer.
Raquel IbáñezEsther RouraLaura MonfilLuis Alejandro Rodríguez-GuerreroMontserrat SardàNàyade CrespoAmparo PascualClara MartíMontserrat FiblaCristina GutiérrezBelén LloverasGloria OliverasAnna TorrentIsabel CatalàFrancesc Xavier BoschLaia BruniSilvia de SanjoséPublished in: PloS one (2020)
HPV detection shows a high longitudinal predictive value at 9-year to identify women at risk to develop CIN2+. The data validate a safe extension of the 3-year screening intervals (current screening interval) to 5-year intervals in underscreened women that had negative HPV result at baseline. It is necessary to establish mechanisms to ensure screening participation and adequate follow-up for these women.